Teoxane SA

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0001992112
All SEC filings
View on sec.gov
Issuer % of Class Filed
Revance Therapeutics, Inc. 13D/A Amendment 4
RVNC · 761330109
 6.2% 1/30/2025
Event 1/30/2025
Revance Therapeutics, Inc. 13D/A Amendment 3
RVNC · 761330109
 6.2% 1/6/2025
Event 1/6/2025
Revance Therapeutics, Inc. 13D/A Amendment 2
RVNC · 761330109
 6.2% 12/19/2024
Event 12/19/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.